Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

NGNENeurogene Inc.

Nasdaq · CIK 0001404644
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts447

Identity from submissions API

NameNeurogene Inc.
CIK0001404644
TickersNGNE
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN980542593
LEI—
Fiscal year end1231
State of incorporation—
Phone(877) 237-5020
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Neoleukin Therapeutics, Inc. (2019-08-12T04:00:00.000Z → 2023-12-06T05:00:00.000Z)
  • AQUINOX PHARMACEUTICALS, INC (2013-12-19T05:00:00.000Z → 2019-08-12T04:00:00.000Z)
  • AQUINOX PHARMACEUTICALS (USA) INC (2007-06-25T04:00:00.000Z → 2013-12-24T05:00:00.000Z)
Business address
535 W 24TH STREET
5TH FLOOR
NEW YORK
NY
10011
NY
Mailing address
535 W 24TH STREET
5TH FLOOR
NEW YORK
NY
10011
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

756 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001699737-26-000026 005-88050 261562787 34 19601
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-128384 005-88050 261561554 34 19726
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493215-26-000196 005-88050 261555652 34 11058
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005052 005-88050 261555114 34 15337
2026-11-09 10-Q 10-Q 0001404644-26-000069 001-36327 261535799 34 8152933 1 1
2026-11-09 8-K 8-K 2.02,9.01 0001404644-26-000064 001-36327 261533960 34 8946050 1 1
2026-10-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001137774-26-000205 005-88050 261445994 34 7898
2026-10-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000053417-26-000058 005-88050 261443284 34 6737
2026-10-02 4 FORM 4 0001606302-26-000007 7399
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097193 005-88050 261282000 34 13069
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-038383 005-88050 261281867 34 12051
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003430 005-88050 261275830 34 15145
2026-08-11 10-Q 10-Q 0001404644-26-000059 001-36327 261264192 34 8058722 1 1
2026-08-11 8-K 8-K 2.02,9.01 0001404644-26-000056 001-36327 261260626 34 8819975 1 1
2026-07-07 4 FORM 4 0001543663-26-000017 8368
2026-07-02 4 FORM 4 0001543663-26-000015 10327
2026-07-02 8-K 8-K 1.01,8.01,9.01 0001404644-26-000050 001-36327 261147292 34 728740 1 1
2026-07-02 424B5 424B5 0001628280-26-046666 333-286057 261147272 33 453304
2026-06-30 424B5 424B5 0001628280-26-046237 333-286057 261140752 33 448077
2026-06-29 8-K 8-K 7.01,8.01,9.01 0001404644-26-000046 001-36327 261131419 34 5654034 1 1
2026-06-16 4/A FORM 4/A 0001996804-26-000011 6151
2026-06-16 4/A FORM 4/A 0001996804-26-000010 5913
2026-06-16 4/A FORM 4/A 0001996804-26-000009 13567
2026-06-16 3/A FORM 3/A 0001996804-26-000008 3796
2026-06-08 8-K 8-K 7.01,9.01 0001404644-26-000044 001-36327 261071038 34 5023943 1 1
2026-06-04 8-K 8-K 5.07 0001404644-26-000040 001-36327 261065615 34 157564 1 1
2026-05-12 8-K 8-K 2.02,9.01 0001404644-26-000038 001-36327 26968474 34 5067712 1 1
2026-05-12 10-Q 10-Q 0001404644-26-000037 001-36327 26968381 34 7193008 1 1
2026-05-08 4 FORM 4 0001543663-26-000013 8339
2026-05-07 4 FORM 4 0001934412-26-000006 6021
2026-05-06 144 xsl144X01/primary_doc.xml 0001968582-26-000406 001-36327 26948582 33 5888
2026-04-20 3 FORM 3 0001934412-26-000004 11179
2026-04-20 8-K 8-K 5.02,7.01,9.01 0001404644-26-000030 001-36327 26873354 34 176848 1 1
2026-04-16 ARS ARS 0001140361-26-015144 001-36327 26867874 34 9422014
2026-04-16 DEFA14A DEFA14A 0001404644-26-000028 001-36327 26867780 34 1089318
2026-04-16 DEF 14A DEF 14A 0001404644-26-000027 001-36327 26867771 34 3595863 1 1
2026-03-30 4 FORM 4 0001543663-26-000011 6721
2026-03-30 4 FORM 4 0001606302-26-000005 6468
2026-03-30 4 FORM 4 0001968554-26-000005 6579
2026-03-24 S-8 S-8 0001404644-26-000022 333-294567 26786425 33 278070 1 1
2026-03-24 10-K 10-K 0001404644-26-000019 001-36327 26786141 34 9836273 1 1
2026-03-24 8-K 8-K 2.02,9.01 0001404644-26-000012 001-36327 26784185 34 8418560 1 1
2026-03-17 4 FORM 4 0001994301-26-000004 10051
2026-03-17 4 FORM 4 0001543663-26-000007 10458
2026-03-13 144 xsl144X01/primary_doc.xml 0001950047-26-002581 001-36327 26752743 33 4987
2026-03-03 4 FORM 4 0001543663-26-000005 6381
2026-02-27 144 xsl144X01/primary_doc.xml 0001968582-26-000175 001-36327 26701180 33 4735
2026-02-26 8-K 8-K 7.01,9.01 0001404644-26-000006 001-36327 26687651 34 177273 1 1
2026-02-24 4 FORM 4 0001994301-26-000002 5873
2026-02-24 4 FORM 4 0001968554-26-000002 15762
2026-02-24 4 FORM 4 0001543663-26-000002 15954
2026-02-24 4 FORM 4 0001606302-26-000002 16010
2026-02-24 4 FORM 4 0001628280-26-011325 5662
2026-02-24 4 FORM 4 0001274826-26-000002 5685
2026-02-24 4 FORM 4 0001706301-26-000002 5677
2026-02-24 4 FORM 4 0001832569-26-000002 5697
2026-02-24 4 FORM 4 0001996804-26-000002 5686
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-016440 005-88050 26641554 34 19005
2026-01-12 8-K 8-K 7.01,9.01 0001404644-26-000003 001-36327 26524623 34 4202722 1 1
2025-12-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-027814 005-88050 251572763 34 24304
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000698 005-88050 251485277 34 16901
2025-11-13 8-K 8-K 2.02,9.01 0001404644-25-000103 001-36327 251479713 34 5439233 1 1
2025-11-13 10-Q 10-Q 0001404644-25-000101 001-36327 251479452 34 7884318 1 1
2025-11-12 8-K 8-K 7.01,9.01 0001404644-25-000098 001-36327 251474189 34 3484006 1 1
2025-11-06 8-K 8-K 7.01,9.01 0001404644-25-000091 001-36327 251456167 34 5580809 1 1
2025-10-09 8-K 8-K 7.01,9.01 0001404644-25-000088 001-36327 251383595 34 5531075 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001831942-25-000013 005-88050 251220840 34 12044
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-078656 005-88050 251219796 34 16685
2025-08-11 424B5 424B5 0001628280-25-039623 333-286057 251202679 33 322877
2025-08-11 8-K 8-K 2.02,9.01 0001404644-25-000082 001-36327 251202062 34 5917962 1 1
2025-08-11 10-Q 10-Q 0001404644-25-000081 001-36327 251201984 34 7771295 1 1
2025-06-30 8-K 8-K 7.01,9.01 0001404644-25-000070 001-36327 251091905 34 5523140 1 1
2025-06-13 4 FORM 4 0001404644-25-000068 311753
2025-06-13 4 FORM 4 0001404644-25-000067 312830
2025-06-13 4 FORM 4 0001404644-25-000066 311983
2025-06-13 4 FORM 4 0001404644-25-000065 312019
2025-06-13 4 FORM 4 0001404644-25-000064 312150
2025-06-12 8-K 8-K 5.02,5.07,9.01 0001404644-25-000053 001-36327 251042962 34 473139 1 1
2025-06-09 8-K 8-K 8.01,9.01 0001404644-25-000049 001-36327 251032835 34 6273957 1 1
2025-05-15 4 FORM 4 0001404644-25-000046 13246
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-049481 005-88050 25953620 34 21393
2025-05-14 144 xsl144X01/primary_doc.xml 0001950047-25-003006 001-36327 25946182 33 4987
2025-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-001532 005-88050 25933271 34 11584
2025-05-09 8-K 8-K 2.02,9.01 0001404644-25-000044 001-36327 25928388 34 2248632 1 1
2025-05-09 10-Q 10-Q 0001404644-25-000041 001-36327 25928376 34 6886022 1 1
2025-04-25 ARS ARS 0001404644-25-000037 001-36327 25870696 34 57126124
2025-04-25 DEFA14A DEFA14A 0001404644-25-000035 001-36327 25870638 34 517170
2025-04-25 DEF 14A DEF 14A 0001404644-25-000034 001-36327 25870634 34 3817995 1 1
2025-04-23 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-001515 005-88050 25863270 34 11073
2025-04-14 8-K 8-K 1.01,8.01,9.01 0001404644-25-000029 001-36327 25836538 34 173559 1 1
2025-04-04 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000988 333-286057 25816230 33 2022
2025-04-02 CORRESP filename1.htm 0001628280-25-016058 141902
2025-04-01 424B3 424B3 0001628280-25-015981 333-283561 25800968 33 169261
2025-03-31 UPLOAD filename1.pdf 0000000000-25-003412 333-286057 40278
2025-03-28 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000829 333-283561 25788528 33 2035
2025-03-28 4 FORM 4 0001404644-25-000025 7459
2025-03-28 4 FORM 4 0001404644-25-000023 7714
2025-03-28 4 FORM 4 0001404644-25-000021 7591
2025-03-28 4 FORM 4 0001404644-25-000020 7619
2025-03-24 S-3 S-3 0001628280-25-014521 333-286057 25764594 33 825827
2025-03-24 POS AM POS AM 0001628280-25-014517 333-283561 25764573 33 378372
2025-03-24 S-8 S-8 0001628280-25-014508 333-286055 25764556 33 274625
2025-03-24 8-K 8-K 2.02,9.01 0001404644-25-000014 001-36327 25764327 34 7454429 1 1
2025-03-24 10-K 10-K 0001404644-25-000012 001-36327 25764119 34 12267891 1 1
2025-03-17 4 FORM 4 0001404644-25-000007 6072
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-014381 005-88050 25632094 34 14475
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001188 005-88050 25629729 34 12645
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-25-001515 005-88050 25628014 34 19579
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000044 005-88050 25625167 34 9764
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-020490 005-88050 25623681 34 11231
2025-01-13 8-K 8-K 7.01,9.01 0001404644-25-000004 001-36327 25524806 34 7216716 1 1
2024-12-18 424B3 424B3 0001628280-24-051855 333-283561 241559131 33 4957486
2024-12-16 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-12-16 16:01:00 9999999995-24-003791 333-283561 241553497 33 2030
2024-12-12 CORRESP filename1.htm 0001628280-24-050972 21168
2024-12-11 SC 13G formsc13g.htm 0001493152-24-049633 005-88050 241541539 34 101590
2024-12-09 UPLOAD filename1.pdf 0000000000-24-013517 333-283561 40316
2024-12-02 S-1 S-1 0001628280-24-049615 333-283561 241520225 33 19804203 1 1
2024-11-27 4 xslF345X05/form4-11272024_091125.xml 0001415889-24-027861 15698
2024-11-27 3 xslF345X02/form3-11272024_091102.xml 0001415889-24-027859 11201
2024-11-27 SC 13G/A SC 13G/A 0001104659-24-123711 005-88050 241511553 34 67353
2024-11-25 4 FORM 4 0001404644-24-000113 5499
2024-11-25 4 FORM 4 0001404644-24-000112 5406
2024-11-21 8-K 8-K 7.01 0001404644-24-000109 001-36327 241484167 34 149598 1 1
2024-11-18 10-Q 10-Q 0001404644-24-000104 001-36327 241472532 34 7645799 1 1
2024-11-18 8-K 8-K 2.02,9.01 0001404644-24-000103 001-36327 241472519 34 233825 1 1
2024-11-18 8-K 8-K 7.01,9.01 0001404644-24-000097 001-36327 241469731 34 180269 1 1
2024-11-14 SC 13G/A greatpoint-ngne093024a2.htm 0001172661-24-005298 005-88050 241463785 34 116140
2024-11-14 NT 10-Q NT 10-Q 0001404644-24-000094 001-36327 241461556 34 53298
2024-11-14 SC 13G/A JANUS AMENDMENT 0001274173-24-000142 005-88050 241460945 34 10763
2024-11-14 SC 13G/A cormorant-ngne093024a1.htm 0001172661-24-005049 005-88050 241460755 34 88742
2024-11-14 SC 13G NEUROGENE INC. 0000902664-24-006490 005-88050 241456924 34 66496
2024-11-12 SC 13G filing.txt 0000315066-24-002828 005-88050 241444862 34 8361
2024-11-12 8-K 8-K 7.01,9.01 0001404644-24-000091 001-36327 241442802 34 6842495 1 1
2024-11-08 SC 13G d11515888_13-g.htm 0000919574-24-006263 005-88050 241441206 34 130049
2024-11-04 8-K 8-K 1.01,3.02,7.01,9.01 0001404644-24-000089 001-36327 241420763 34 867625 1 1
2024-08-09 10-Q 10-Q 0001404644-24-000086 001-36327 241192960 34 6905151 1 1
2024-08-09 8-K 8-K 2.02,9.01 0001404644-24-000085 001-36327 241190411 34 5316950 1 1
2024-08-07 8-K 8-K 7.01,9.01 0001404644-24-000083 001-36327 241181459 34 185988 1 1
2024-07-08 SC 13G us64135m1053_070824.txt 0001086364-24-008261 005-88050 241105305 34 13579
2024-06-21 8-K 8-K 7.01,9.01 0001404644-24-000080 001-36327 241058399 34 5155289 1 1
2024-06-18 8-K 8-K 7.01,9.01 0001404644-24-000073 001-36327 241051017 34 183363 1 1
2024-06-17 4 FORM 4 0001404644-24-000071 5789
2024-06-17 4 FORM 4 0001404644-24-000070 5781
2024-06-17 4 FORM 4 0001404644-24-000069 5805
2024-06-17 4 FORM 4 0001404644-24-000068 5796
2024-06-17 4 FORM 4 0001404644-24-000067 5780
2024-06-17 8-K 8-K 5.07 0001404644-24-000066 001-36327 241047788 34 161694 1 1
2024-06-03 8-K 8-K 7.01,9.01 0001404644-24-000059 001-36327 241011995 34 181807 1 1
2024-05-10 10-Q 10-Q 0001404644-24-000057 001-36327 24935005 34 6320310 1 1
2024-05-10 8-K 8-K 2.02,9.01 0001404644-24-000054 001-36327 24932899 34 5039841 1 1
2024-05-07 8-K 8-K 7.01,9.01 0001404644-24-000049 001-36327 24919476 34 192892 1 1
2024-04-26 DEFA14A DEFA14A 0001404644-24-000045 001-36327 24882238 34 351764
2024-04-26 ARS ARS 0001404644-24-000044 001-36327 24882225 34 27027368
2024-04-26 DEF 14A DEF 14A 0001404644-24-000043 001-36327 24882222 34 3462223 1 1
2024-04-25 8-K 8-K 5.02,9.01 0001404644-24-000041 001-36327 24872132 34 157068 1 1
2024-04-22 8-K 8-K 7.01,9.01 0001404644-24-000029 001-36327 24861719 34 182587 1 1
2024-04-02 8-K 8-K 5.02 0001404644-24-000026 001-36327 24813900 34 157692 1 1
2024-03-18 8-K 8-K 2.02,9.01 0001404644-24-000024 001-36327 24759133 34 236615 1 1
2024-03-18 10-K 10-K 0001404644-24-000020 001-36327 24758964 34 11081043 1 1
2024-03-14 4 FORM 4 0001404644-24-000010 5792
2024-03-14 4 FORM 4 0001404644-24-000008 7082
2024-03-14 4 FORM 4 0001404644-24-000006 7096
2024-03-07 144 xsl144X01/primary_doc.xml 0001950047-24-002031 001-36327 24730564 33 4990
2024-03-04 144 xsl144X01/primary_doc.xml 0001950047-24-001815 001-36327 24717121 33 10908
2024-03-04 8-K 8-K 7.01,9.01 0001193125-24-056852 001-36327 24712854 34 14002534 1 1
2024-02-21 8-K 8-K 5.02 0001193125-24-041440 001-36327 24659425 34 144410 1 1
2024-02-20 S-8 S-8 0001193125-24-039982 333-277186 24653528 33 418380
2024-02-14 SC 13G neurogene13g.htm 0000935836-24-000214 005-88050 24641069 34 49505
2024-02-14 SC 13G/A greatpoint-ngne123123a1.htm 0001172661-24-001525 005-88050 24639405 34 117382
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023789 005-88050 24638933 34 95341
2024-02-14 SC 13G SC 13G 0001104659-24-023672 005-88050 24638506 34 83026
2024-02-14 SC 13G sc13g.htm 0000929638-24-000655 005-88050 24636612 34 151878
2024-02-14 SC 13G JHG PLC OWNS >5% 0001274173-24-000062 005-88050 24635856 34 10756
2024-02-14 SC 13G/A NEUROGENE INC. 0000902664-24-001606 005-88050 24633021 34 65032
2024-02-09 144 xsl144X01/primary_doc.xml 0001950047-24-000814 001-36327 24615618 33 4847
2024-02-06 144 xsl144X01/primary_doc.xml 0001950047-24-000702 001-36327 24600500 33 4963
2024-01-18 4 4 0000950170-24-005541 5580
2024-01-18 4 4 0000950170-24-005539 14283
2024-01-18 4 4 0000950170-24-005537 15203
2024-01-18 4 4 0000950170-24-005535 5571
2024-01-18 4 4 0000950170-24-005533 5596
2024-01-18 4 4 0000950170-24-005531 5732
2024-01-18 3 3 0000950170-24-005530 12661
2024-01-05 8-K 8-K 7.01,9.01 0001193125-24-002861 001-36327 24514426 34 4313835 1 1
2023-12-27 SC 13G greatpoint-ngne121823.htm 0001172661-23-004088 005-88050 231517971 34 116929
2023-12-26 3 3 0000950170-23-073112 19895
2023-12-26 3 3 0000950170-23-073110 21158
2023-12-26 3 3 0000950170-23-073109 13561
2023-12-26 3 3 0000950170-23-073108 17100
2023-12-26 3 3 0000950170-23-073104 18677
2023-12-26 3 3 0000950170-23-073103 12570
2023-12-22 SC 13G/A SC 13G/A 0001104659-23-128807 005-88050 231509964 34 100809
2023-12-21 SC 13D SC 13D 0001193125-23-301182 005-88050 231505318 34 37777
2023-12-20 4 FORM 4 SUBMISSION 0001209191-23-059388 46915
2023-12-20 SC 13D/A SC 13D/A 0001104659-23-127789 005-88050 231502213 34 113898
2023-12-19 8-K 8-K 1.01,2.01,3.03,5.01,5.02,5.03,5.05,5.07,5.08,7.01,9.01 0001193125-23-298152 001-36327 231495635 34 2593278 1 1
2023-12-06 425 425 0001193125-23-289925 001-36327 231469898 34 66079
2023-12-06 8-K 8-K 8.01 0001193125-23-289922 001-36327 231469856 34 212561 1 1
2023-12-04 425 425 0001193125-23-288509 001-36327 231464288 34 172573
2023-12-04 8-K 8-K 8.01,9.01 0001193125-23-288502 001-36327 231464246 34 342677 1 1
2023-11-30 425 425 0001193125-23-286269 001-36327 231455758 34 33774
2023-11-14 10-Q 10-Q 0001628280-23-038797 001-36327 231401704 34 4678793 1 1
2023-11-13 SEC STAFF LETTER filename1.pdf 9999999997-23-004660 63325
2023-11-13 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2023-11-13 16:00:00 9999999995-23-003297 333-274095 231401243 33 1919
2023-11-08 CORRESP filename1.htm 0001193125-23-273405 8279
2023-11-08 CORRESP filename1.htm 0001193125-23-273399 21320
2023-11-08 S-4/A S-4/A 0001193125-23-273390 333-274095 231387317 33 20474179 1 1
2023-10-18 CORRESP filename1.htm 0001193125-23-258483 34363
2023-10-18 S-4/A S-4/A 0001193125-23-258478 333-274095 231332346 33 18851468 1 1
2023-10-10 SEC STAFF LETTER filename1.pdf 9999999997-23-004726 65724
2023-10-10 SC 13D/A SCHEDULE 13D/A 0001104659-23-108324 005-88050 231318459 34 85035
2023-10-10 4 FORM 4 SUBMISSION 0001209191-23-052526 27467
2023-10-10 UPLOAD filename1.pdf 0000000000-23-011090 48624
2023-10-05 425 425 0001193125-23-251340 001-36327 231310686 34 29441
2023-09-28 CORRESP filename1.htm 0001193125-23-245689 74536
2023-09-28 S-4/A S-4/A 0001193125-23-245680 333-274095 231290082 33 19799329 1 1
2023-09-22 8-K 8-K 3.03,5.03,8.01,9.01 0001628280-23-032817 001-36327 231270264 34 235442 1 1
2023-09-18 UPLOAD filename1.pdf 0000000000-23-010257 71101
2023-08-21 S-4 S-4 0001193125-23-216091 333-274095 231186919 33 18285332 1 1
2023-08-17 SC 13D/A SC 13D/A 0001104659-23-093112 005-88050 231182868 34 120102
2023-08-17 4 FORM 4 SUBMISSION 0001209191-23-046351 39927
2023-08-14 4 FORM 4 SUBMISSION 0001209191-23-045611 10445
2023-08-10 10-Q 10-Q 0001628280-23-028856 001-36327 231159523 34 4640425 1 1
2023-07-27 SC 13D SCHEDULE 13D 0001104659-23-084840 005-88050 231119421 34 350916
2023-07-19 SC 13D/A SC 13D/A 0001104659-23-082423 005-88050 231097630 34 370759
2023-07-18 425 425 0001193125-23-188840 001-36327 231094265 34 57259
2023-07-18 425 425 0001193125-23-188524 001-36327 231093079 34 13676380
2023-07-18 8-K 8-K 1.01,3.02,5.01,5.02,7.01,9.01 0001193125-23-188522 001-36327 231093074 34 14195413 1 1
2023-06-12 4 FORM 4 SUBMISSION 0001209191-23-036241 22222
2023-06-12 8-K 8-K 5.07 0001628280-23-021819 001-36327 231007572 34 213699 1 1
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035869 5511
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035866 5620
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035861 5635
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035857 5664
2023-06-09 4 FORM 4 SUBMISSION 0001209191-23-035853 5653
2023-05-08 10-Q 10-Q 0001628280-23-016425 001-36327 23898017 34 4825105 1 1
2023-04-27 ARS ARS 0001140361-23-020829 001-36327 23854960 34 832393
2023-04-27 DEFA14A DEFA14A 0001628280-23-013446 001-36327 23853973 34 406042
2023-04-27 DEF 14A DEF 14A 0001628280-23-013445 001-36327 23853947 34 5400931
2023-04-14 PRE 14A PRE 14A 0001628280-23-011646 001-36327 23821816 34 5385960
2023-04-04 4 FORM 4 SUBMISSION 0001209191-23-023100 10203
2023-04-03 8-K 8-K 5.02 0001628280-23-010410 001-36327 23793618 34 171321 1 1
2023-03-21 S-8 S-8 0001628280-23-008655 333-270704 23747485 33 127539
2023-03-20 10-K 10-K 0001628280-23-008602 001-36327 23746396 34 6439332 1 1
2023-03-10 8-K 8-K 2.05,5.02 0001628280-23-007432 001-36327 23721695 34 177586 1 1
2023-03-08 8-K 8-K 7.01,9.01 0001628280-23-007026 001-36327 23716879 34 208484 1 1
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021673 005-88050 23629779 34 83839
2023-02-03 4 FORM 4 SUBMISSION 0001209191-23-006886 10160
2023-02-03 4 FORM 4 SUBMISSION 0001209191-23-006881 10521
2023-02-03 SC 13G SC 13G 0001193125-23-023731 005-88050 23584541 34 35148
2023-01-23 8-K/A 8-K/A 5.03,9.01 0001628280-23-001398 001-36327 23544716 34 494558 1 1
2023-01-19 SC 13G/A NLTX_SC13GA1_2023.htm 0001273087-23-000039 005-88050 23537537 34 81902
2022-12-30 SC 13G NEOLEUKIN THERAPEUTICS, INC. 0000902664-22-005339 005-88050 221502267 34 68119
2022-11-30 8-K 8-K 5.03,9.01 0001628280-22-031095 001-36327 221436092 34 476493 1 1
2022-11-14 10-Q 10-Q 0001628280-22-029833 001-36327 221385386 34 4514960 1 1
2022-11-14 8-K 8-K 2.02,7.01,9.01 0001628280-22-029828 001-36327 221385148 34 3865869 1 1
2022-10-31 8-K 8-K 3.01 0001628280-22-027409 001-36327 221345981 34 167179 1 1
2022-08-12 4 FORM 4 SUBMISSION 0001209191-22-045667 10151
2022-08-09 10-Q 10-Q 0001628280-22-021923 001-36327 221148305 34 4344562 1 1
2022-08-09 8-K 8-K 2.02,7.01,9.01 0001628280-22-021916 001-36327 221148201 34 5301394 1 1
2022-08-04 4 FORM 4 SUBMISSION 0001209191-22-044435 5688
2022-08-04 4 FORM 4 SUBMISSION 0001209191-22-044434 5678
2022-08-04 4 FORM 4 SUBMISSION 0001209191-22-044433 5688
2022-08-04 4 FORM 4 SUBMISSION 0001209191-22-044432 5654
2022-08-04 4 FORM 4 SUBMISSION 0001209191-22-044430 5707
2022-07-27 8-K 8-K 7.01 0001628280-22-019499 001-36327 221108970 34 197704 1 1
2022-07-19 SC 13G NLTX_SC13G_J2022.htm 0001273087-22-000092 005-88050 221091657 34 81850
2022-07-15 SC 13G NLTX_SC13G_July2022.htm 0001273087-22-000091 005-88050 221086338 34 82215
2022-07-08 SC 13G us64049k1043_070822.txt 0000834237-22-010343 005-88050 221075095 34 12397
2022-07-07 SC 13G NLTX_SC13G.htm 0001273087-22-000088 005-88050 221072176 34 82205
2022-05-18 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-05-18 16:00:00 9999999995-22-001522 333-264803 22941069 33 1918
2022-05-16 4 FORM 4 SUBMISSION 0001209191-22-029326 9035
2022-05-16 4 FORM 4 SUBMISSION 0001209191-22-029325 5588
2022-05-16 4 FORM 4 SUBMISSION 0001209191-22-029324 9172
2022-05-16 4 FORM 4 SUBMISSION 0001209191-22-029323 9192
2022-05-16 4 FORM 4 SUBMISSION 0001209191-22-029321 9177
2022-05-16 4 FORM 4 SUBMISSION 0001209191-22-029115 17288
2022-05-16 CORRESP filename1.htm 0001193125-22-151004 8269
2022-05-16 8-K 8-K 5.07 0001628280-22-014413 001-36327 22925624 34 204519 1 1
2022-05-13 UPLOAD filename1.pdf 0000000000-22-005258 40382
2022-05-09 S-3 S-3 0001193125-22-145088 333-264803 22905875 33 237988
2022-05-09 10-Q 10-Q 0001628280-22-013306 001-36327 22905020 34 3260453 1 1
2022-05-09 8-K 8-K 2.02,9.01 0001628280-22-013298 001-36327 22904949 34 255003 1 1
2022-05-03 4 FORM 4 SUBMISSION 0001209191-22-026894 10434
2022-03-31 DEFA14A DEFA14A 0001628280-22-008019 001-36327 22792444 34 348957
2022-03-31 DEF 14A DEF 14A 0001628280-22-008017 001-36327 22792361 34 4572271
2022-03-15 4 FORM 4 SUBMISSION 0001209191-22-018936 5709
2022-03-15 3 FORM 3 SUBMISSION 0001209191-22-018935 7151
2022-03-04 4 FORM 4 SUBMISSION 0001209191-22-016454 5567
2022-03-04 3 FORM 3 SUBMISSION 0001209191-22-016427 7034
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015479 5690
2022-03-03 3 FORM 3 SUBMISSION 0001209191-22-015471 14076
2022-03-01 S-8 S-8 0001628280-22-004502 333-263190 22700018 33 132772
2022-03-01 10-K 10-K 0001628280-22-004491 001-36327 22698013 34 6283483 1 1
2022-03-01 8-K 8-K 2.02,5.02,9.01 0001628280-22-004490 001-36327 22697963 34 275436 1 1
2022-02-15 8-K 8-K 5.02 0001193125-22-042937 001-36327 22637120 34 142212 1 1
2022-02-14 5 FORM 5 SUBMISSION 0001209191-22-009562 13496
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-023143 005-88050 22634501 34 79217
2022-02-14 SC 13G/A neoleukintherapeutics13ga.htm 0000935836-22-000163 005-88050 22630121 34 50174
2022-02-11 SC 13G/A SC 13G/A 0001193125-22-036995 005-88050 22620767 34 39409
2022-02-11 SC 13G/A SC 13G/A 0001193125-22-036982 005-88050 22620758 34 39577
2022-02-10 SC 13G SC 13G 0001193125-22-033906 005-88050 22612075 34 34784
2022-02-03 SC 13G/A us64049k1043_020222.txt 0000834237-22-005513 005-88050 22585796 34 13391
2022-02-02 4 FORM 4 SUBMISSION 0001209191-22-006398 9639
2022-02-02 4 FORM 4 SUBMISSION 0001209191-22-006395 9631
2022-02-02 4 FORM 4 SUBMISSION 0001209191-22-006391 9544
2022-01-10 8-K 8-K 7.01,8.01,9.01 0001628280-22-000567 001-36327 22519779 34 5242419 1 1
2021-11-19 8-K 8-K 5.02 0001193125-21-334588 001-36327 211426454 34 142444 1 1
2021-11-16 8-K 8-K 8.01,9.01 0001193125-21-330743 001-36327 211414197 34 10428751 1 1
2021-11-04 8-K 8-K 1.01,9.01 0001193125-21-320321 001-36327 211380916 34 405155 1 1
2021-11-04 424B5 424B5 0001193125-21-320305 333-251294 211380866 33 484155
2021-11-04 10-Q 10-Q 0001628280-21-021773 001-36327 211380079 34 3941148 1 1
2021-11-04 8-K 8-K 2.02,9.01 0001628280-21-021763 001-36327 211379999 34 262995 1 1
2021-09-29 8-K 8-K 7.01,8.01,9.01 0001628280-21-019240 001-36327 211289446 34 2618425 1 1
2021-08-26 4 FORM 4 SUBMISSION 0001209191-21-053544 9293
2021-08-05 4 FORM 4 SUBMISSION 0001209191-21-049941 5689
2021-08-05 4 FORM 4 SUBMISSION 0001209191-21-049930 5682
2021-08-05 4 FORM 4 SUBMISSION 0001209191-21-049928 5686
2021-08-05 10-Q 10-Q 0001628280-21-015861 001-36327 211148380 34 3656280 1 1
2021-08-05 4 FORM 4 SUBMISSION 0001209191-21-049923 5640
2021-08-05 4 FORM 4 SUBMISSION 0001209191-21-049919 5655
2021-08-05 8-K 8-K 2.02,7.01,9.01 0001628280-21-015849 001-36327 211148247 34 4611332 1 1
2021-06-17 4 FORM 4 SUBMISSION 0001209191-21-041814 4978
2021-06-11 4 FORM 4 SUBMISSION 0001209191-21-039819 5478
2021-06-09 4 FORM 4 SUBMISSION 0001209191-21-039223 4978
2021-06-07 4 FORM 4 SUBMISSION 0001209191-21-038696 4978
2021-06-07 4 FORM 4 SUBMISSION 0001209191-21-038690 7082
2021-06-02 8-K FORM 8-K 7.01,9.01 0001193125-21-179289 001-36327 21987711 34 8627644
2021-05-26 4 FORM 4 SUBMISSION 0001209191-21-036057 4977
2021-05-21 4 FORM 4 SUBMISSION 0001209191-21-035020 5174
2021-05-14 8-K 8-K 5.07,9.01 0001628280-21-010230 001-36327 21922001 34 306471
2021-05-13 4 FORM 4 SUBMISSION 0001209191-21-032406 5643
2021-05-13 4 FORM 4 SUBMISSION 0001209191-21-032404 5481
2021-05-13 4 FORM 4 SUBMISSION 0001209191-21-032401 5605
2021-05-13 4 FORM 4 SUBMISSION 0001209191-21-032400 5590
2021-05-13 4 FORM 4 SUBMISSION 0001209191-21-032397 5623
2021-05-13 4 PRIMARY DOCUMENT 0001638599-21-000464 17225
2021-05-12 4 FORM 4 SUBMISSION 0001209191-21-032244 4978
2021-05-12 10-Q 10-Q 0001628280-21-009912 001-36327 21913533 34 3244590 1 1
2021-05-12 8-K 8-K 2.02,7.01 0001628280-21-009911 001-36327 21913529 34 4856217
2021-05-06 4 FORM 4 SUBMISSION 0001209191-21-030654 4978
2021-05-04 4 FORM 4 SUBMISSION 0001209191-21-029907 8491
2021-05-04 3 FORM 3 SUBMISSION 0001209191-21-029904 7047
2021-04-30 4 FORM 4 SUBMISSION 0001209191-21-029342 5476
2021-04-27 4 FORM 4 SUBMISSION 0001209191-21-028727 4977
2021-04-22 4 FORM 4 SUBMISSION 0001209191-21-027971 5472
2021-04-16 4 FORM 4 SUBMISSION 0001209191-21-027050 4978
2021-04-08 4 FORM 4 SUBMISSION 0001209191-21-026153 4978
2021-04-06 4 FORM 4 SUBMISSION 0001209191-21-025767 4977
2021-04-02 4 FORM 4 SUBMISSION 0001209191-21-024707 5472
2021-03-31 DEFA14A DEFA14A 0001193125-21-102244 001-36327 21793220 34 399753
2021-03-31 DEF 14A DEF 14A 0001193125-21-102235 001-36327 21793167 34 542769
2021-03-25 S-8 S-8 0001193125-21-094640 333-254725 21773581 33 76540
2021-03-25 10-K 10-K 0001628280-21-005630 001-36327 21772667 34 7193139 1 1
2021-03-25 8-K 8-K 2.02,9.01 0001628280-21-005620 001-36327 21772594 34 100050
2021-03-24 4 FORM 4 SUBMISSION 0001209191-21-022929 7037
2021-03-18 4 FORM 4 SUBMISSION 0001209191-21-021946 4976
2021-03-18 4 FORM 4 SUBMISSION 0001209191-21-021943 9602
2021-03-11 4 FORM 4 SUBMISSION 0001209191-21-019776 5474
2021-03-04 4 FORM 4 SUBMISSION 0001209191-21-017994 5474
2021-02-25 4 FORM 4 SUBMISSION 0001209191-21-014513 6541
2021-02-18 4 FORM 4 SUBMISSION 0001209191-21-011834 5473
2021-02-16 SC 13G SC 13G 0001104659-21-023979 005-88050 21638409 34 80491
2021-02-16 SC 13G/A nltx13ga.htm 0000935836-21-000154 005-88050 21634735 34 47583
2021-02-12 SC 13G SC 13G 0001193125-21-041634 005-88050 21628020 34 36122
2021-02-12 SC 13G SC 13G 0001193125-21-041625 005-88050 21627992 34 37900
2021-02-12 4 FORM 4 SUBMISSION 0001209191-21-010148 4977
2021-02-09 4 FORM 4 SUBMISSION 0001209191-21-008839 4978
2021-02-05 4 FORM 4 SUBMISSION 0001209191-21-008129 4979
2021-02-02 4 FORM 4 SUBMISSION 0001209191-21-006730 5692
2021-02-02 3 FORM 3 SUBMISSION 0001209191-21-006729 9909
2021-02-02 SC 13G us64049k1043_020221.txt 0000834237-21-007104 005-88050 21580827 34 13401
2021-01-11 8-K 8-K 7.01,9.01 0001193125-21-005875 001-36327 21519516 34 9000766
2020-12-23 4 PRIMARY DOCUMENT 0001638599-20-000993 25614
2020-12-23 SC 13D/A SC 13D/A 0001104659-20-139213 005-88050 201413439 34 107343
2020-12-21 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-12-21 16:00:00 9999999995-20-003602 333-251294 201405942 33 1919
2020-12-17 CORRESP filename1.htm 0001193125-20-320037 8879
2020-12-16 UPLOAD filename1.pdf 0000000000-20-012115 40396
2020-12-11 S-3 S-3 0001193125-20-315863 333-251294 201383597 33 724090
2020-12-01 8-K FORM 8-K 1.01 0001193125-20-307046 001-36327 201360916 34 17304
2020-11-09 10-Q 10-Q 0001564590-20-052218 001-36327 201296189 34 4659325 1
2020-11-09 8-K 8-K 2.02,9.01 0001564590-20-052212 001-36327 201296163 34 193899
2020-10-20 4 FORM 4 SUBMISSION 0001209191-20-055395 5650
2020-10-20 3 FORM 3 SUBMISSION 0001209191-20-055394 6743
2020-09-10 4 FORM 4 SUBMISSION 0001209191-20-049966 5616
2020-09-10 3 FORM 3 SUBMISSION 0001209191-20-049960 6733
2020-09-10 8-K FORM 8-K 5.02 0001193125-20-242679 001-36327 201167790 34 19949
2020-08-12 4 FORM 4 SUBMISSION 0001209191-20-046342 5604
2020-08-12 4 FORM 4 SUBMISSION 0001209191-20-046339 9185
2020-08-12 10-Q 10-Q 0001564590-20-039671 001-36327 201095489 34 3935920 1
2020-08-12 8-K 8-K 2.02,9.01 0001564590-20-039662 001-36327 201095426 34 182886
2020-08-03 8-K FORM 8-K 7.01 0001193125-20-208195 001-36327 201069986 34 16609
2020-07-02 8-K 8-K 1.01,8.01,9.01 0001193125-20-186835 001-36327 201009356 34 311357
2020-07-02 424B5 424B5 0001193125-20-186822 333-223584 201009305 33 546857
2020-07-01 424B5 424B5 0001193125-20-185196 333-223584 201005495 33 550446
2020-06-02 4 FORM 4 SUBMISSION 0001209191-20-033543 5567
2020-06-02 3 FORM 3 SUBMISSION 0001209191-20-033538 6723
2020-06-01 8-K FORM 8-K 5.02 0001193125-20-156617 001-36327 20931080 34 22572
2020-05-07 4 PRIMARY DOCUMENT 0001638599-20-000417 17162
2020-05-07 4 FORM 4 SUBMISSION 0001209191-20-027694 9182

Latest XBRL company facts

One latest value per concept from companyfacts (447 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 20.70M 2026-11-05 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
dei EntityPublicFloat Entity Public Float USD 145.98M 2025-06-30 2025 FY 10-K 2026-03-24 0001404644-26-000019
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 2.13M 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001404644-26-000027
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.11M 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001404644-26-000027
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 202 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001404644-26-000027
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 32,000 2015-12-31 2015 FY 10-K 2016-03-14 0001193125-16-503435
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 3.66M 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 3.90M 2020-09-30 2020 Q3 10-Q 2020-11-09 0001564590-20-052218
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 9.55M 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.29M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 478,000 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 2.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap AccruedIncomeTaxesNoncurrent Accrued Income Taxes, Noncurrent USD 0 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093873
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 12.87M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 188,000 2016-12-31 2016 FY 10-K 2017-03-09 0001193125-17-076939
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 16.47M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 801.89M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 5.15M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 17,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 16.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 320,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-09 0001193125-17-076939
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 100,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 3.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 33,300 2020-09-30 2020 Q3 10-Q 2020-11-09 0001564590-20-052218
us-gaap AssetAcquisitionConsiderationTransferredContingentConsideration AssetAcquisitionConsiderationTransferredContingentConsideration USD 400,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap AssetAcquisitionContingentConsiderationLiabilityCurrent AssetAcquisitionContingentConsiderationLiabilityCurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap AssetAcquisitionContingentConsiderationLiabilityNoncurrent AssetAcquisitionContingentConsiderationLiabilityNoncurrent USD 407,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 120,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap Assets Assets USD 377.90M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap AssetsCurrent Assets, Current USD 362.74M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 56.05M 2017-12-31 2018 FY 10-K 2019-03-07 0001193125-19-066506
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 3,000 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 3,000 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 77.99M 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedGain Debt Securities, Available-for-sale, Unrealized Gain USD 10,000 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-12 0001193125-15-183189
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 0 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-04 0001193125-14-395314
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2015-09-30 2015 Q3 10-Q 2015-11-10 0001193125-15-372837
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value USD 0 2015-09-30 2015 Q3 10-Q 2015-11-10 0001193125-15-372837
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 56.05M 2017-12-31 2018 FY 10-K 2019-03-07 0001193125-19-066506
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost USD 56.12M 2017-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079210
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value USD 56.05M 2017-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079210
us-gaap AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year USD 56.12M 2017-12-31 2018 FY 10-K 2019-03-07 0001193125-19-066506
us-gaap AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year USD 56.05M 2017-12-31 2018 FY 10-K 2019-03-07 0001193125-19-066506
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 104.33M 2017-06-30 2017 Q2 10-Q 2017-08-08 0001193125-17-250714
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 104.13M 2017-06-30 2017 Q2 10-Q 2017-08-08 0001193125-17-250714
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 77.99M 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 53.28M 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap AvailableForSaleSecuritiesNoncurrent Available-for-sale Securities, Noncurrent USD 50.05M 2016-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079210
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 43,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001404644-26-000059
us-gaap CapitalizedComputerSoftwareAmortization1 Capitalized Computer Software, Amortization USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap CapitalizedComputerSoftwareImpairments1 Capitalized Computer Software, Impairments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap CapitalizedComputerSoftwareNet Capitalized Computer Software, Net USD 300,000 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 16,000 2017-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079210
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 65,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-07 0001193125-19-066506
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 6,000 2018-12-31 2018 FY 10-K 2019-03-07 0001193125-19-066506
us-gaap CapitalLeasesFutureMinimumPaymentsDue Capital Leases, Future Minimum Payments Due USD 55,000 2017-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079210
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 19,000 2017-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079210
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFourYears Capital Leases, Future Minimum Payments Due in Four Years USD 14,000 2016-12-31 2016 FY 10-K 2017-03-09 0001193125-17-076939
us-gaap CapitalLeasesFutureMinimumPaymentsDueInThreeYears Capital Leases, Future Minimum Payments Due in Three Years USD 17,000 2017-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079210
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 19,000 2017-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079210
us-gaap CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments Capital Leases, Future Minimum Payments, Interest Included in Payments USD 6,000 2017-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079210
us-gaap CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments USD 49,000 2017-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079210
us-gaap Cash Cash USD 21.20M 2020-03-31 2020 Q1 10-Q 2020-05-06 0001564590-20-021920
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001404644-25-000012
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 78.94M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 14.58M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001193125-18-155359
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 269.00M 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 79.28M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -24.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 118.20M 2020-03-31 2020 Q1 10-Q 2020-05-06 0001564590-20-021920
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 0.076 2023-12-18 2023 FY 10-K 2024-03-18 0001404644-24-000020
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 1.83M 2023-12-18 2024 Q3 10-Q 2024-11-18 0001404644-24-000104
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 12.66M 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2019-12-31 2019 FY 10-K 2020-03-12 0001193125-20-071545
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 13.51M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 450.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 20.69M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 20.69M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap CommonStockValue Common Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -20.79M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap ContractualObligation Contractual Obligation USD 1.25M 2024-06-30 2024 Q2 10-Q 2024-08-09 0001404644-24-000086
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 234,000 2024-06-30 2024 Q2 10-Q 2024-08-09 0001404644-24-000086
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 605,000 2024-06-30 2024 Q2 10-Q 2024-08-09 0001404644-24-000086
us-gaap ContractualObligationDueInThirdYear Contractual Obligation, to be Paid, Year Three USD 414,000 2024-06-30 2024 Q2 10-Q 2024-08-09 0001404644-24-000086
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001404644-25-000012
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 10.47M 2023-12-18 2024 FY 10-K 2025-03-24 0001404644-25-000012
us-gaap ConvertiblePreferredDividendsNetOfTax Convertible Preferred Dividends, Net of Tax USD 0 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0001404644-25-000012
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 7.23M 2023-12-18 2024 FY 10-K 2025-03-24 0001404644-25-000012
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 22.80M 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap DebtSecuritiesHeldToMaturityAllowanceForCreditLoss Debt Securities, Held-to-maturity, Allowance for Credit Loss USD 0 2023-12-31 2023 FY 10-K 2024-03-18 0001404644-24-000020
us-gaap DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss USD 343.45M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap DeferredCompensationArrangementWithIndividualExercisePrice Deferred Compensation Arrangement with Individual, Exercise Price USD/shares 5.76 2013-06-25 2014 Q3 10-Q 2014-11-04 0001193125-14-395314
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 572,000 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 139,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 313,000 2018-12-31 2019 FY 10-K 2020-03-12 0001193125-20-071545
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 446,000 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 140.35M 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 11.06M 2019-12-31 2019 FY 10-K 2020-03-12 0001193125-20-071545
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 572,000 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 80.37M 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 26.36M 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 0 2020-12-31 2020 FY 10-K 2021-03-25 0001628280-21-005630
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 168,000 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 18.86M 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 3.27M 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 1.07M 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 139.78M 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 572,000 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 1.80M 2014-12-31 2015 FY 10-K 2016-03-14 0001193125-16-503435
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 410,000 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 600,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap DepositsMoneyMarketDeposits Deposits, Money Market Deposits USD 108,300 2020-09-30 2020 Q3 10-Q 2020-11-09 0001564590-20-052218
us-gaap Depreciation Depreciation USD 1.40M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 2.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 124,000 2015-12-31 2016 FY 10-K 2017-03-09 0001193125-17-076939
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 69.62M 2014-03-31 2014 Q1 10-Q 2014-05-13 0001193125-14-195836
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -3.9 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.64 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001628280-21-005630
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -3.9 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.266 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001628280-21-005630
us-gaap EffectiveIncomeTaxRateReconciliationDispositionOfBusiness Effective Income Tax Rate Reconciliation, Disposition of Business, Percent pure 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004491
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004491
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.033 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-07 0001193125-19-066506
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001628280-21-005630
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.022 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001628280-21-005630
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.038 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001404644-25-000012
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.011 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001404644-25-000012
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.016 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.026 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.081 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 8,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001193125-18-155359
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-05 0001628280-21-015861
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 5.41M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 1.00M 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 19.30M 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-13 0001193125-19-290610
us-gaap FairValueNetAssetLiability Fair Value, Net Asset (Liability) USD 120.67M 2017-03-31 2017 Q1 10-Q 2017-05-09 0001193125-17-163318
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3 Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers into Level 3 USD 0 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-04 0001193125-14-395314
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 70,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 19,000 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 20,000 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 0 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 14,000 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 1,000 2023-12-31 2023 FY 10-K 2024-03-18 0001404644-24-000020
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 1,000 2024-12-31 2024 FY 10-K 2025-03-24 0001404644-25-000012
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 1,000 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 5,000 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 15,000 2024-09-30 2024 Q3 10-Q 2024-11-18 0001404644-24-000104
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 1,000 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 12,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 6,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 16,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization Finance Lease, Right-of-Use Asset, before Accumulated Amortization USD 22,000 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.102 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 659,000 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 100,000 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004491
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 100,000 2020-12-31 2020 FY 10-K 2021-03-25 0001628280-21-005630
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 659,000 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 0 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap ForeignCurrencyExchangeRateTranslation1 Foreign Currency Exchange Rate, Translation pure 0.745 2016-12-31 2016 FY 10-K 2017-03-09 0001193125-17-076939
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -1,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004491
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-05 0001628280-21-015861
us-gaap ForeignCurrencyTransactionLossBeforeTax Foreign Currency Transaction Loss, before Tax USD 26,000 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-10 0001193125-16-584833
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD 81,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-07 0001193125-19-066506
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 47,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD -300,000 2020-06-01 2020-06-30 2021 FY 10-K 2022-03-01 0001628280-22-004491
us-gaap GainOrLossOnSaleOfStockInSubsidiary Gain (Loss) on Disposition of Stock in Subsidiary USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004491
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 28.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss USD 618,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap HeldToMaturitySecuritiesFairValue Debt Securities, Held-to-maturity, Fair Value USD 342.83M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 3.42M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -90.35M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -90.35M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004491
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -33.28M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001628280-21-005630
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 24.01M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 26,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-09 0001193125-17-076939
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -18.97M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 649,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-09 0001193125-17-076939
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 92,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 231,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-09 0001193125-17-076939
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 1.46M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap IncomeTaxReconciliationTaxCreditsInvestment Effective Income Tax Rate Reconciliation, Tax Credit, Investment, Amount USD 5,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-14 0001193125-16-503435
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 7.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap IncreaseDecreaseInAccountsAndOtherReceivables Increase (Decrease) in Accounts and Other Receivables USD -34,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-14 0001193125-16-503435
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 319,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -5.61M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities Increase (Decrease) in Accounts Payable and Other Operating Liabilities USD 2.26M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 2.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -2.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 536,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 318,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001404644-25-000012
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001404644-25-000012
us-gaap InterestExpense Interest Expense USD 3,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-10 0001404644-24-000057
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 2.97M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 391,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-09 0001193125-16-763805
us-gaap InterestIncomeSecuritiesUSTreasuryAndOtherUSGovernment Interest Income, Securities, US Treasury and Other US Government USD 1.00M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-07 0001193125-19-066506
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 4,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079210
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 7.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap InvestmentIncomeNet Investment Income, Net USD 19,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004491
us-gaap InvestmentsAndCash Investments and Cash USD 359.70M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 700,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-12 0001193125-20-071545
us-gaap LeaseCost Lease, Cost USD 2.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 200,000 2020-06-30 2020 Q3 10-Q 2020-11-09 0001564590-20-052218
us-gaap LesseeFinanceLeaseDiscountRate Lessee, Finance Lease, Discount Rate pure 0.071 2019-09-30 2019 Q3 10-Q 2019-11-13 0001193125-19-290610
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.06 2019-09-30 2019 Q3 10-Q 2019-11-13 0001193125-19-290610
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 11.38M 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 2.83M 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three USD 70,000 2019-06-30 2019 Q2 10-Q 2019-08-01 0001193125-19-209916
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two USD 209,000 2019-06-30 2019 Q2 10-Q 2019-08-01 0001193125-19-209916
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months USD 206,000 2019-06-30 2019 Q2 10-Q 2019-08-01 0001193125-19-209916
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 3.85M 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 614,000 2024-12-31 2024 FY 10-K 2025-03-24 0001404644-25-000012
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 614,000 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 3.32M 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 3.59M 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 982,000 2024-09-30 2024 Q3 10-Q 2024-11-18 0001404644-24-000104
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.51M 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap Liabilities Liabilities USD 23.11M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 377.90M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001628280-21-005630
us-gaap LiabilitiesCurrent Liabilities, Current USD 18.16M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap LineOfCredit Long-term Line of Credit USD 2.29M 2013-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093873
us-gaap LineOfCreditFacilityAmountOutstanding Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD 2.29M 2013-12-31 2014 Q1 10-Q 2014-05-13 0001193125-14-195836
us-gaap LineOfCreditFacilityIncreaseAccruedInterest Line of Credit Facility, Increase, Accrued Interest USD 9,844 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093873
us-gaap LoansPayableToBankCurrent Loans Payable to Bank, Current USD 250,000 2013-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093873
us-gaap LongTermInvestments Long-term Investments USD 8.14M 2014-09-30 2014 Q3 10-Q 2014-11-04 0001193125-14-395314
us-gaap LongTermLoansFromBank Loans Payable to Bank, Noncurrent USD 2.04M 2013-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093873
us-gaap MinorityInterestOwnershipPercentageByParent Noncontrolling Interest, Ownership Percentage by Parent pure 1 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093873
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 167.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 423,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079210
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -113.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 64.01M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079210
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -79.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -44.72M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079210
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -94.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -37.00M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-09 0001193125-17-076939
us-gaap NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 Noncash or Part Noncash Acquisition, Intangible Assets Acquired USD 186,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-09 0001193125-17-076939
us-gaap NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Other Liabilities Assumed USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001404644-25-000012
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001404644-25-000012
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 12.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap OperatingExpenses Operating Expenses USD 102.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -102.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 585,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 146,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 9.87M 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 3.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 4.54M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap OperatingLeasePayments Operating Lease, Payments USD 3.97M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 2.06M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 884,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 978,000 2018-12-31 2019 FY 10-K 2020-03-12 0001193125-20-071545
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 362,000 2018-12-31 2019 FY 10-K 2020-03-12 0001193125-20-071545
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 292,000 2016-12-31 2016 FY 10-K 2017-03-09 0001193125-17-076939
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears Operating Leases, Future Minimum Payments, Due in Four and Five Years USD 0 2015-12-31 2015 FY 10-K 2016-03-14 0001193125-16-503435
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 312,000 2017-12-31 2017 FY 10-K 2018-03-12 0001193125-18-079210
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 280,000 2018-12-31 2019 FY 10-K 2020-03-12 0001193125-20-071545
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoAndThreeYears Operating Leases, Future Minimum Payments, Due in Two and Three Years USD 0 2015-12-31 2015 FY 10-K 2016-03-14 0001193125-16-503435
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 336,000 2018-12-31 2019 FY 10-K 2020-03-12 0001193125-20-071545
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 0 2015-12-31 2015 FY 10-K 2016-03-14 0001193125-16-503435
us-gaap OperatingLeasesRentExpenseSubleaseRentals1 Operating Leases, Rent Expense, Sublease Rentals USD 127,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-09 0001193125-17-076939
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.099 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 124.90M 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.17M 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap OtherAssetsCurrent Other Assets, Current USD 122,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.57M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD 21,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -3,855 2014-03-13 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093873
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 70,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-12 0001193125-20-071545
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 612,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 14,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-06 0001564590-20-021920
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 45,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 451,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -12,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004491
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 4,943 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-04 0001193125-14-395314
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 242,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 4.69M 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-07 0001193125-19-066506
us-gaap PaymentsForProceedsFromTenantAllowance Payments for (Proceeds from) Tenant Allowance USD 8.00M 2019-12-23 2020 Q1 10-Q 2020-05-06 0001564590-20-021920
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 350 2003-12-26 2014-03-31 2014 Q1 10-Q 2014-05-13 0001193125-14-195836
us-gaap PaymentsForRestructuring Payments for Restructuring USD 2.69M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap PaymentsOfLoanCosts Payments of Loan Costs USD 100,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093873
us-gaap PaymentsOfMergerRelatedCostsFinancingActivities Payments of Merger Related Costs, Financing Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 6.00M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-12 0001193125-20-071545
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 91.88M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap PaymentsToAcquireHeldToMaturitySecurities Payments to Acquire Held-to-maturity Securities USD 436.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 183,629 2003-12-26 2014-03-31 2014 Q1 10-Q 2014-05-13 0001193125-14-195836
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 950,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 2.82M 2003-12-26 2014-03-31 2014 Q1 10-Q 2014-05-13 0001193125-14-195836
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 1 2019-08-08 2019 Q3 10-Q 2019-11-13 0001193125-19-290610
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 50.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.02M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 2.52M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ProceedsFromInterestReceived Proceeds from Interest Received USD 435,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-06 0001564590-20-021920
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 98.04M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-10 0001193125-15-372837
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 67,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-18 0001404644-24-000020
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 84,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 3,393 2013-03-01 2013-03-31 2014 FY 10-K 2015-03-16 0001193125-15-093873
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 2.50M 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093873
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 99.00M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 720,863 2003-12-26 2014-03-31 2014 Q1 10-Q 2014-05-13 0001193125-14-195836
us-gaap ProceedsFromRepaymentsOfDebt Proceeds from (Repayments of) Debt USD -2.60M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-09 0001193125-17-076939
us-gaap ProceedsFromRepurchaseOfRedeemablePreferredStock Proceeds from (Repurchase of) Redeemable Preferred Stock USD 18.00M 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-14 0001193125-16-503435
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 56.00M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-12 0001193125-20-071545
us-gaap ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities Proceeds from Sale and Maturity of Held-to-maturity Securities USD 324.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 2.12M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 994,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -20.64M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001564590-20-052218
us-gaap PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization USD 2.95M 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization USD 6.16M 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization USD 9.12M 2022-12-31 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 1.80M 2023-04-01 2023-06-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 27.65M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 11.19M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap PurchaseObligation Purchase Obligation USD 800,000 2020-12-31 2020 FY 10-K 2021-03-25 0001628280-21-005630
us-gaap PurchaseObligationDueAfterFifthYear Purchase Obligation, to be Paid, after Year Five USD 0 2015-12-31 2015 FY 10-K 2016-03-14 0001193125-16-503435
us-gaap PurchaseObligationDueInFourthAndFifthYear Purchase Obligation, to be Paid, Year Four and Five USD 0 2015-12-31 2015 FY 10-K 2016-03-14 0001193125-16-503435
us-gaap PurchaseObligationDueInNextTwelveMonths Purchase Obligation, to be Paid, Year One USD 2.16M 2015-12-31 2015 FY 10-K 2016-03-14 0001193125-16-503435
us-gaap PurchaseObligationDueInSecondAndThirdYear Purchase Obligation, to be Paid, Year Two and Three USD 0 2015-12-31 2015 FY 10-K 2016-03-14 0001193125-16-503435
us-gaap RepaymentsOfDebt Repayments of Debt USD 2.60M 2014-01-01 2014-09-30 2015 Q3 10-Q 2015-11-10 0001193125-15-372837
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 2.61M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093873
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 2,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-06 0001564590-20-021920
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 255,775 2003-12-26 2014-03-31 2014 Q1 10-Q 2014-05-13 0001193125-14-195836
us-gaap ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff Research and Development Asset Acquired Other than Through Business Combination, Written-off USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001628280-21-005630
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 74.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 39.16M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001628280-22-004491
us-gaap RestrictedCash Restricted Cash USD 339,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 508,000 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 339,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap RestructuringAndRelatedCostExpectedCost1 Restructuring and Related Cost, Expected Cost USD 1.80M 2022-11-14 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap RestructuringAndRelatedCostExpectedCostRemaining1 Restructuring and Related Cost, Expected Cost Remaining USD 184,000 2018-09-30 2018 Q3 10-Q 2018-11-07 0001193125-18-320293
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.4 2022-11-14 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap RestructuringCharges Restructuring Charges USD 2.11M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap RestructuringReserve Restructuring Reserve USD 900,000 2023-12-18 2023 FY 10-K 2024-03-18 0001404644-24-000020
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -447.09M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 71.30M 2020-07-05 2020-07-07 2020 Q3 10-Q 2020-11-09 0001564590-20-052218
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 11 2014-03-12 2014 FY 10-K 2015-03-16 0001193125-15-093873
us-gaap SecurityDeposit Security Deposit USD 500,000 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 16.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 4,771 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-18 0001404644-24-000104
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 36.06 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-18 0001404644-24-000104
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 482,384 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-18 0001404644-24-000104
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 0 2023-12-31 2024 Q3 10-Q 2024-11-18 0001404644-24-000104
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.868 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.974 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.95 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.037 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.046 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.036 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 4.50M 2019-11-12 2019 FY 10-K 2020-03-12 0001193125-20-071545
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 4.71M 2019-09-30 2019 Q3 10-Q 2019-11-13 0001193125-19-290610
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 793,799 2015-12-31 2015 FY 10-K 2016-03-14 0001193125-16-503435
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 8.80M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.24M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 24.29 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 100,000 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 520 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-07 0001193125-19-066506
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 128,382 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 24.17 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 859,867 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 476,460 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-04 0001193125-16-671769
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 17 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 21.90M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 3.01M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 22.94 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 0 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 13.64 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 10.56 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-07 0001193125-19-066506
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 27.06 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001628280-23-038797
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 21.39 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 12.25 2016-09-23 2016 Q3 10-Q 2016-11-09 0001193125-16-763805
us-gaap ShortTermInvestments Short-term Investments USD 280.78M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 38,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 354.79M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance (Deprecated 2020-01-31) USD 144.66M 2016-12-31 2019 FY 10-K 2020-03-12 0001193125-20-071545
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.25 2023-12-18 2024 FY 10-K 2025-03-24 0001404644-25-000012
us-gaap StockIssued1 Stock Issued USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001404644-25-000012
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 419,700 2019-11-01 2019-11-30 2022 FY 10-K 2023-03-20 0001628280-23-008602
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 18,352 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001628280-21-005630
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 13.51M 2023-12-18 2024 FY 10-K 2025-03-24 0001404644-25-000012
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 81,288 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 38.21M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0001404644-25-000012
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 244.37M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0001404644-25-000012
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 77.33M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-09 0001193125-17-076939
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 67,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 47.34M 2014-03-13 2014-03-31 2014 Q1 10-Q 2014-05-13 0001193125-14-195836
us-gaap StockIssuedDuringPeriodValueIssuedForNoncashConsiderations Development Stage Entities, Stock Issued, Value, Issued for Noncash Consideration (Deprecated 2015-01-31) USD 186,356 2014-03-13 2014-12-31 2014 FY 10-K 2015-03-16 0001193125-15-093873
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 41,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-25 0001628280-21-005630
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 134.88M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 30.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 15.05M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-25 0001628280-21-005630
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2021-01-01 2021-03-31 2022 Q1 10-Q 2022-05-09 0001628280-22-013306
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 771,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 350 2005-01-01 2005-12-31 2014 Q1 10-Q 2014-05-13 0001193125-14-195836
us-gaap SubleaseIncome Sublease Income USD 400,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 20,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-09 0001193125-17-076939
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2023-12-31 2023 FY 10-K 2024-03-18 0001404644-24-000020
us-gaap UnrealizedGainLossOnSecurities Unrealized Gain (Loss) on Securities USD 880 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-11 0001193125-14-304867
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 4.82M 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 1.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 320,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 4.80M 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 24.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-24 0001404644-26-000019
us-gaap VariableLeaseCost Variable Lease, Cost USD 1.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 74,000 2016-03-31 2016 Q1 10-Q 2016-05-10 0001193125-16-584833
us-gaap WarrantsNotSettleableInCashFairValueDisclosure Warrants Not Settleable in Cash, Fair Value Disclosure USD 412,038 2013-03-31 2014 FY 10-K 2015-03-16 0001193125-15-093873
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 398,573 2003-12-26 2014-03-31 2014 Q1 10-Q 2014-05-13 0001193125-14-195836
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 24.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 51.83M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001628280-21-005630
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 24.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001404644-26-000069

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →